Trophoblast glycoprotein is a new candidate gene for Parkinson's disease.

Park, Sanghyun; Yoo, Jeong-Eun; Yeon, Gyu-Bum; Kim, Jin Hee; Lee, Jae Souk; Choi, Sung Kyoung; Hwang, Young-Gi; Park, Chan Wook; Cho, Myung Soo; Kim, Jongwan; Na, Dokyun; Kim, Hyung Wook; Kim, Dae-Sung; Kim, Dong-Wook

Parkinson's disease (PD) is a movement disorder caused by progressive degeneration of the midbrain dopaminergic (mDA) neurons in the substantia nigra pars compacta (SNc). Despite intense research efforts over the past decades, the etiology of PD remains largely unknown. Here, we discovered the involvement of trophoblast glycoprotein (Tpbg) in the development of PD-like phenotypes in mice. Tpbg expression was detected in the ventral midbrain during embryonic development and in mDA neurons in adulthood. Genetic ablation of Tpbg resulted in mild degeneration of mDA neurons in aged mice (12–14 months) with behavioral deficits reminiscent of PD symptoms. Through in silico analysis, we predicted potential TPBG-interacting partners whose functions were relevant to PD pathogenesis; this result was substantiated by transcriptomic analysis of the SNc of aged Tpbg knockout mice. These findings suggest that Tpbg is a new candidate gene associated with PD and provide a new insight into PD pathogenesis.

TROPHOBLAST; GLYCOPROTEINS; PARKINSON'S disease; MOVEMENT disorders; PHENOTYPES; MICE

NPJ Parkinson's Disease, 2021, Vol 7, Issue 1, p1

2373-8057

Academic Journal

10.1038/s41531-021-00252-0